Seeking Alpha

Reports that Allscripts (MDRX +14.2%) is exploring a sale should not come as a big shock...

Reports that Allscripts (MDRX +14.2%) is exploring a sale should not come as a big shock considering the calls earlier this year from major shareholder HealthCor for MDRX to put itself on the block. HealthCor has since seen three of its own nominees added to the board, which would help push the case to sell. Other medical records firms also move up: QSII +3.9%, CERN +3.9%.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs